Commercial drug compendium information: a First World/Third World comparison

Area of Science:

• Pharmacovigilance
• Drug Information Science
• Global Health Policy

Background:

• Commercial drug compendia are vital resources for healthcare professionals.
• Disparities in drug information accessibility may exist between developed (First World) and developing (Third World) countries.
• Understanding these differences is crucial for ensuring patient safety and effective pharmacotherapy globally.

Purpose of the Study:

• To compare the content comprehensiveness and accuracy of commercial drug compendium monographs in First World versus Third World countries.
• To identify potential gaps in essential drug information provided in developing nations.

Main Methods:

• A content model was developed using monographs from prominent First World drug compendia (Physicians' Desk Reference, ABPI Data Sheet Compendium, Rote Liste).
• A sample of 58 monographs from four Third World drug compendia, representing five World Health Organization Essential Drugs, was evaluated.
• Monographs were assessed for comprehensiveness against the First World model and for accuracy.

Main Results:

• First World compendia showed variability in content, with Physicians' Desk Reference being the most comprehensive.
• Third World drug compendia monographs were significantly less comprehensive than any First World compendium.
• Approximately 5% of information in Third World monographs was inaccurate.
• Monograph content did not differ between multinational and domestic pharmaceutical firms in the Third World sample.

Conclusions:

• Drug compendia in Third World countries present less comprehensive and potentially less accurate information compared to First World resources.
• There is a need to improve the quality and completeness of drug information in developing nations.
• International standards for drug compendia content may be lacking, even among industrialized nations.